Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice
- 1 September 2015
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 291, 1-11
Abstract
No abstract availableKeywords
Funding Information
- North Savo Regional Fund
- Research Council of Finland
- Jane and Aatos Erkko Foundation
This publication has 31 references indexed in Scilit:
- Lenti‐GDNF Gene Therapy Protects Against Alzheimer's Disease‐Like Neuropathology in 3xTg‐AD Mice and MC65 CellsCNS Neuroscience & Therapeutics, 2014
- Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning testExperimental Neurology, 2013
- Gene therapy with AAV2‐CDNF provides functional benefits in a rat model of Parkinson's diseaseBrain and Behavior, 2013
- Identification of Novel GDNF Isoforms and cis-Antisense GDNFOS Gene and Their Regulation in Human Middle Temporal Gyrus of Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's diseaseJournal of Neurochemistry, 2005
- A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseNature Medicine, 2005
- Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s diseaseMolecular Brain Research, 2003
- The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's DiseaseMolecular and Cellular Neuroscience, 2001
- Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factorNature, 1987